VPS healthcare expands global footprint into the United Kingdom with 'super-speciality' hospital

New center, based in West London, will open in 2017 with a bed capacity of 150, supported by 1,000 staff in jobs ranging from administration, support and service.

  
London, UK: 28 July 2015 - VPS Healthcare, an integrated healthcare services provider, is pleased to announce its international expansion into the UK health sector with a new 'super-speciality' hospital focused on cancer treatment.

The new hospital will be the first private facility in the UK to offer Proton Beam Therapy - a type of radiotherapy that uses sub-atomic particles to attack cancer cells with less damage to surrounding tissues than conventional radiotherapy.

The new centre, based in West London, will open in 2017 with a bed capacity of 150and will be supported by around 1,000 staff in jobs ranging from administration, support and service roles to leading specialist healthcare professionals.  

The investment has been welcomed by the Mayor of London Boris Johnson who last year launched MedCity, an initiative to drive forward life sciences research and development, entrepreneurship and commercialisation in England's greater south east.

The Mayor of London, Boris Johnson, said: "This is a tremendous vote of confidence in London's thriving life sciences sector as well as the skills and talent of our amazing healthcare professionals. London is a world leader in medical sciences and through MedCity we are working to generate the jobs and growth that will propel this important sector to even greater things."

Commenting on today's announcement, the Founder and Managing Director of VPS, Dr. Shamsheer Vayalil, said: "At a time when the Middle East's healthcare sector is undergoing a phase of rapid growth, the entry of VPS into the UK market is testament to the world-class technological innovation and healthcare expertise stemming from the region.  

VPS has been encouraged by the UK Government's ongoing policy to support health and pharmaceutical companies, and we believe that our investment in this dynamic sector will not only ensure that we play a key role in supporting this initiative, but will also help to grow and develop the next generation of medical breakthroughs." 

The launch was marked by a special event on Monday 27th July, being attended by VPS management and dignitaries, at the legendary London hotel, The Dorchester.

*Proton Beam Therapy ('PBT')

Proton therapy is considered the most advanced and targeted cancer radiotherapy treatment due to its superior dose distribution and fewer side effects.

The UAE is poised to become the first centre in the Middle East Africa and Asia region to have the revolutionary Proton Beam Therapy treatment for cancer by 2018 in Abu Dhabi, work for which will begin later this year.

About VPS Healthcare Group
VPS Healthcare is one of the leading healthcare providers in the Middle East and India, with a particular focus on cancer care from public awareness, prevention and screening to manufacturing treatments and providing specialist care. The company owns a network of hospitals, medical centres, pharmaceutical manufacturing operations, an international pharmacy retail chain and medical support services, and currently employs over 7,500 people.

VPS Healthcare is recognized as a Global Growth Company by the World Economic Forum (WEF) and is also a member of the MENA Regional Partnership Community of the WEF. In addition to this, the company is also the proud holder of the Guinness World Record for Largest Simultaneous Self-Examination for Breast Cancer.

For more information, visit www.vpshealth.com

About MedCity
Established by the Mayor of London with the capital's three Academic Health Science Centres - Imperial College Academic Health Centre, King's Health Partners, and UCL Partners - MedCity is a unique collaboration that brings together the outstanding life sciences strengths of London and the greater south east.

Over the next 20 years, MedCity will position the region as a world-leading, interconnected hub for research, development, manufacturing and commercialisation by championing collaboration and entrepreneurship, promoting a joined up and globally distinct life sciences offer, and providing a visible 'go-to' point for industry and investors.

For more information, visit www.medcitylondon.com

For media enquiries, please contact:
Alisa D'souza
Public Relations Director
Blue Apple Mediacom FZ LLC 
2008, Al Thuraya Tower 2, 
Dubai Media City 
Dubai, UAE 
Mob: +97150 7858298
Tel  : +9714 4390161 
www.blueappleco.com  
Communication|Engagement|Experience

Yusra Farzan
PR Account Executive
Blue Apple Mediacom FZ LLC 
2008, Al Thuraya Tower 2, 
Dubai Media City 
Dubai, UAE 
Mob: +97150 4229958
Tel: +9714 4390161  
www.blueappleco.com
Communication|Engagement|Experience

© Press Release 2015

More From Press Releases